Donald DeGolyer

Donald DeGolyer

Director/Board Member bei EMERGENT BIOSOLUTIONS INC.

Vermögen: 300 235 $ am 31.03.2024

63 Jahre
Health Technology
Consumer Services
Commercial Services

Profil

Donald W.
DeGolyer
was the founder and had founded Vertice Pharma LLC in 2015, where he held the title of President & Chief Executive Officer.
Currently, he is serving as an Independent Director at Emergent BioSolutions, Inc. since 2023, at Tyme, Inc. since 2018, at Vertice Pharma UK Parent Ltd., at Vertice Pharma UK Holdings Ltd.
as Secretary & Director since 2015, at Vertice Pharma UK Intermediate Ltd.
as Secretary & Director since 2015, and at Xevant, Inc. since 2023.
In his former positions, he served as President & Chief Executive Officer at Sandoz, Inc., Vice Chairman at Association for Accessible Medicines, Independent Director at Tyme Technologies, Inc. from 2018 to 2022, Independent Director at HLS Therapeutics, Inc., Principal at Johnson & Johnson, Vice President-Marketing & Sales at Pfizer Inc., Chief Operating Officer at Endo Pharmaceuticals, Inc. from 2013 to 2015, President-Global Therapeutics at Oxford GlycoSciences Plc, and SVP-Managed Markets & Established Medicines at Novartis Pharmaceuticals Corp.
He also served as Chief Operating Officer & Executive Vice President at ParkStone Medical Info Systems.
Mr. DeGolyer completed his undergraduate degree at Rochester Christian University and holds an MBA from Fairleigh Dickinson University.

Bekannte Unternehmensbeteiligungen

UnternehmenDatumAnzahl der AktienBewertungDatum der Bewertung
03.10.2023 118 670 ( 0,23% ) 300 235 $ 31.03.2024
18.05.2023 0 ( -.--% ) - $ 31.03.2024

Aktive Positionen von Donald DeGolyer

UnternehmenPositionBeginn
EMERGENT BIOSOLUTIONS INC. Director/Board Member 28.09.2023
Director/Board Member 03.07.2023
Director/Board Member 21.10.2015
Director/Board Member 21.10.2015
Director/Board Member 31.05.2018
Director/Board Member -
Alle aktiven Positionen von Donald DeGolyer

Ehemalige bekannte Positionen von Donald DeGolyer

UnternehmenPositionEnde
HLS THERAPEUTICS INC. Director/Board Member 16.06.2023
TYME TECHNOLOGIES, INC. Director/Board Member 16.09.2022
Chief Operating Officer 01.07.2015
░░░░░░░ ░░░░ ░░░░░ ░ ░░░░░░░░░ -
░░░░░░░ ░░░░░ ░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ -
Sehen Sie sich die Erfahrung von Donald DeGolyer im Detail an

Ausbildung von Donald DeGolyer

Rochester Christian University Undergraduate Degree
Fairleigh Dickinson University Masters Business Admin

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Donald DeGolyer im Detail an

Beziehungen

69

Beziehungen ersten Grades

20

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Börsennotierte Unternehmen4
JOHNSON & JOHNSON

Health Technology

PFIZER, INC.

Health Technology

EMERGENT BIOSOLUTIONS INC.

Health Technology

HLS THERAPEUTICS INC.

Health Technology

Private Unternehmen14

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

ParkStone Medical Info Systems

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Finance

Technology Services

Sehen Sie sich die Unternehmensverbindungen an
  1. Börse
  2. Insiders
  3. Donald DeGolyer